Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-31
2008-10-14
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S251000
Reexamination Certificate
active
07435740
ABSTRACT:
A class of novel antagonists for the adenosine A3receptor are disclosed. These compounds are useful as therapeutic agents for a number of diseases and medical conditions that are mediated by the A3receptor. The compounds of this invention are also useful as diagnostic agents for the A3receptor.
REFERENCES:
patent: 213881 (1968-03-01), None
patent: 225203 (1968-08-01), None
Eckstein et al., Synthesis of Optically Active Imidazo[1,2-f]purine Systems, Synthesis, Jul. 1983, 577-579.
Muller, C., Medicinal Chemistry of Adenosine A3 Receptor Ligands, Current Topics in Medicinal Chemistry, 3, 445-462 (2003).
Tkachenko, A., et al., Synthesis of Conducting Imidazo[1,2-f]xanthan on Base 8-methyl Mercaptotheofillin, Chemistry of Heterocyclic Compounds, No. 5 (1971).
Tkachenko et al., “Imidazoles. LIV. Synthesis of imidazo[1,2-f]xanthine derivatives based on 8-amino(alkylamino, arylamino)theophyllines”,Khimiya Geterotsiklicheskikh Soedinenii1971, 7(5), 682-685.
Tkachenko et al., “Imidazoles. LV. Synthesis of imidazo[1,2-f]xanthine derivatives based on 8-methyl thiotheophylline”,Khimiya Geterosiklicheskikh Soedinenii1971, 7(5), 686-688.
Kochergin et al., “Imidazoles. LIII. Synthesis and pharmacological action of imidazo(1,2-f)xanthene derivatives”,Khimiko-Farmatsevticheskii Zhurnal1971, 5(2), 22-26.
Kochergin et al., “Synthesis of condensed imidazole system derivatives from 2-haloimidazoles and 8-haloxanthines,”Khimiya Geterotsiklicheskikh Soedinenii1969, (1), 177-178.
Kochergin et al., “Synthesis of imidazo[1,2-f]purine derivatives”,Khimiya Geterotsiklicheskikh Soedinenii1965, (3), 475.
Baraldi et al., “A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines”,Synthesis2001, (5), 773-777.
Tyurin et al., “Computer-aided drug design based on azole-derivative structure-activity relations”,Bashkirskii Khimicheskii Zhurnal1997, 4(4), 49-58.
Romanenko et al., “The synthesis and pharmacological activity of the derivatives of 1-methyl-3H-6,9-dihydro-1,2,4-triazino[3,4-f]xanthine”,Khimiko-Farmatsevticheskii Zhurnal1986, 20(2), 187-190.
Romanenko et al., “Synthesis and biological properties of substituted triazino[3,4-f]xanthines”,Khimiko-Farmatsevticheskii Zhurnal1986, 20(4), 427-430.
Priimenko et al., “Synthesis and study of the reactivity of 1,4-dihydro-1,2,4-triazino(3,4-f)xanthines”,Khimiya i Khimicheskaya Tekhnologiya1981, 24(12), 1495-1499.
Beilis et al., “Study of aromatic amines by the method of oxidative voltammetry. VII. Derivatives of 1,2,4-triazine”,Zhurnal Obshchei Khimii1979, 49(4), 879-883.
Povstyanoi et al., “Synthesis of 1,4-dihydro-1,2,4-triazino[3,4-f]xanthines”,Khimiya i Khimicheskaya Tekhnologiya1975, 18(8), 1316-1319.
Popov et al., “Oxidative condensation of 2-ethylnylbenzimidazole”,Khimiya Geterotsiklicheskikh Soedinenii1974, (12), 1696.
Povstyanoi et al., “Synthesis of condensed 1,2,4-triazine systems from 2(8)-methylmercaptoimidazoles”,Khimiya Geterotsiklicheskikh Soedinenii1974, (12), 1696-1697.
Povstyanoi et al., “Single-stage synthesis of 1,4-dihydro derivatives of as-triazino(3,4-f)xanthine”,Ukrainskii Khimicheskii Zhurnal(Russian Edition) 1974, 40(2), 215-216.
Zelnick et al., “Purines. I. Ketones attached through an α-position to a theophylline, 8-bromotheophylline, or theobromine nucleus”,Bulletin de la Societe Chimique de France1956, 888-892.
Romanenko et al., “Reaction of 7-(acylmethyl)-8-bromo-8-methylxanthines with formamide”,Khimiya Geterotsiklicheskikh Soedinenii, 1986, (8), 1133-35. CAN 106:176323.
Baraldi Pier Giovanni
Borea Pier Andrea
Preti Delia
Tabrizi Mojgan Aghazadeh
King Pharmaceuticals Research and Development, Inc.
Kukkola Paivi
Leeser Erich A
Wilson James O.
LandOfFree
Adenosine A 3 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine A 3 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine A 3 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3991430